The sentinel lymph node biopsy (SLNB) has become established as the gold standard for clinically node-negative patients with primary mammary carcinomas. The OSNA® system allows the intraoperative analysis of the entire lymph node, thus allowing a more accurate assessment of the extent of the metastatic spread. An earlier definitive decision on the necessary therapeutic measures can then be made during the surgical procedure.
OSNA BC System offers the following advantages:
Please contact your local sales representative for further information.